Allergy drug could help Parkinson's patients walk better
NCT ID NCT06785298
Summary
This study is testing whether fexofenadine, a common allergy medication, can improve quality of life for people with Parkinson's disease who are already taking standard treatments. Researchers will add fexofenadine to existing medications to see if it helps with movement problems like slowness, stiffness, and tremors. The trial involves 46 participants aged 50+ with mild to moderate Parkinson's symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta University
RECRUITINGTanta, 31511, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.